15:59 May 29

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
2250.00
-63.00 (-2.72%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Gland Pharma Ltd. Financials

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
2250.00
-63.00 (-2.72%)
15:59 May 29
Quality
image/svg+xml

97/100
High Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

65/100
Technically Moderately Bullish

Strength

15

Weakness

4

Opportunity

1

Threats

0

9.91 %

ROE %

8.21 %

ROA %

62.35

EPS

628.67

BVPS

15.97 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
4400.71 3624.6 5664.72 5616.5 6430.65
Operating Expenses +
2890.55 2599.83 4331.65 4347.58 4801.1
Raw Material
2072.52 1732.34 2275.2 2186.12 2246.35
Increase Decrease in Cost
36.69 -46.92 127.88 103.41 -3.42
Other Manufacturing Expense
95.05 124.84 0 0 0
Employee Cost
338.57 403.26 1256.89 1401.56 1628.84
Miscellaneous Expenses
399.04 417.49 717.82 685.47 942.53
Operating Profit
1510.16 1024.77 1333.07 1268.92 1629.55
Other Income
223.94 240.46 170.24 213.61 316.33
Depreciation
110.3 146.74 344.57 377.87 423.67
Interest
5.24 7.45 26.2 42 33.28
Profit before tax and exceptio..
1618.55 1111.04 1132.54 1062.66 1488.93
Exceptional Items
0 -56.46 0 0 -24.35
PBT
1618.55 1054.58 1132.54 1062.66 1464.58
Provision for Taxation
406.89 273.54 360.08 364.13 437.26
Net Profit
1211.66 781.04 772.46 698.53 1027.32
NET Profit after MI
1211.66 781.04 772.46 698.53 1027.32
EPS
73.81 47.43 46.9 42.4 62.28
Operating Profit Margin (%)
34.32 28.27 23.53 22.59 25.34
Net Profit Margin (%)
27.53 21.55 13.64 12.44 15.98

Gland Pharma Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 51.80 51.80 51.80 51.80 51.80 51.80
FII 7.30 7.60 7.90 7.40 6.90 5.00
Public 33.30 33.00 32.60 32.80 33.30 34.80
Others 7.60 7.60 7.70 8.00 8.00 8.40
Shareholder Shares Holding %
Download Our App On: